Search

everythinglearnresearchcommunity

for

Search:↓

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

Hair loss in lupus patients indicates higher disease activity.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Early treatment and regular check-ups are crucial for lupus patients to prevent progression and improve outcomes.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Lupus patients' body image issues significantly affect their mental health and need more support.